AlphAIAlphAI — Financial news for AI agents
insidermonkey.comSEP 252 min read$WT

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

Original reporting
insidermonkey.com
Published Sep 25, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 12:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move? — source image
Source · insidermonkey.com
Decision brief

The 30-second read

$WTBullishMed
01

Why it matters

The MoonPay integration could unlock new retail inflows and enhance tokenized product visibility, potentially re‑rating the stock.

02

Market read

A fresh strategic partnership that may drive future growth for a mid‑cap asset manager.

03

What to watch

Debt repurchase losses and high effective tax rate could limit near‑term profitability.

Relevance 7/10Novelty 7/10Timing: post-announcement on Sep 17

Background

WisdomTree is a traditional ETF sponsor transitioning to blockchain‑native services, reporting strong operating metrics but recent GAAP losses from debt retirements.

Company-level read

Ticker impact

$WTBullishHigh confidence
Context

WisdomTree announced a new partnership with MoonPay to embed its tokenized money market fund, giving access to 35M accounts.

Expected impact

upside potential if tokenized fund inflows accelerate

Evidence & confidence

First disclosure of a strategic crypto partnership; market may price in growth upside.

Market effects

Sector

Highlights growing interest in tokenized assets within the asset‑management sector.

Regional

U.S. asset managers may see increased competition from crypto‑focused distributors.

Global

Partnership could influence global tokenization trends and stablecoin adoption.

Counterpoint

What could challenge this read

The partnership may distract from core AUM growth and add regulatory risk.

Key entities

  • company
    WisdomTree

    US‑listed asset manager (WT) expanding into crypto tokenization.

  • company
    MoonPay

    Crypto infrastructure provider partnering with WisdomTree.

Read at source← All news

Related articles

OCT 12
$WTMed

WisdomTree reports $13.5B net inflows, 7th record AUM quarter

WisdomTree (NYSE: WT) reported $168.9B in assets under management (AUM) for Q3, marking its seventh record quarter. The firm saw $1.2B in net inflows for September and $13.5B year-to-date, with UCITS products contributing $700M in September. Fixed income led inflows, while emerging market equity saw outflows. WisdomTree's tokenized AUM grew 65% year-to-date to $1.3B. The company's blended average fee rate was 36 basis points.

investing.com2 min
OCT 2
$WTMed

WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

financialcontent.com2 min
OCT 2
$WTMed

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

gurufocus.com2 min
OCT 2
$WTMed

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

gurufocus.com2 min
JUL 31
$WTMed

WisdomTree Announces Second Quarter 2026 Results

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

SEC EDGAR 8-K6 min
JUL 31
$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.

financialcontent.com3 min